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To the Editor: The XVII International AIDS Conference 
was held on 3 - 8 August 2008 in Mexico City, with 24 000 
implementers, activists, persons living with HIV, researchers 
and politicians from 194 nations discussing the conference 
theme: Universal action now!
One of the main messages stressed throughout the 
conference was that a focus on antiretroviral (ARV) treatment 
alone has not and will not win the battle against HIV 
transmission. While increased access to treatment for the 
millions who need it should be supported and expanded, 2 - 3 
persons are newly infected with HIV for each person placed 
on treatment. And while ARVs alone cannot prevent HIV 
transmission, neither can a single prevention strategy. UNAIDS 
director Dr Peter Piot emphasised the need to study the 
regional context of every HIV epidemic carefully so as to apply 
the most appropriate combination of strategies for prevention 
and treatment for the local population. Piot and others stressed 
the need for ‘combination prevention’ – an evidence-based mix 
of context- and epidemic-appropriate prevention strategies 
applied together to enhance the effectiveness of prevention 
efforts.
Ross et al.1 presented a model showing men’s age as a risk 
factor for increased HIV transmission to female partners. The 
‘take-home’ message was that intergenerational sex may be a 
risk factor, and that sex within the same age group may help to 
reduce transmission risk.
Powers et al.’s2 literature review found that the risk of 
transmission among the heterosexual population may exceed 
1 per 1 000 coital acts, depending on genital ulcers and the 
presence of circumcision.
Attia et al.3 presented a literature review that found no 
strong correlation between exposure to ARVs and reduction 
in transmission between discordant couples, owing to limited 
data and the unclear effect of other sexually transmitted 
infections (STIs).
Heneine (on behalf of Parikh et al.4) presented a case-
control experimental trial of 6 monkeys exposed to SHIV 
via a tenofovir-based vaginal gel. None of the study group 
seroconverted, while 86% of a control group that did not 
receive ARVs seroconverted. In addition to this and other 
research, there was a resounding call to use HIV funding to 
support health systems as well as to urgently address human 
rights violations, gender inequality and stigmatisation, to 
further support the successful continued scale-up of treatment 
and combination prevention efforts.
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HIV prevention and transmission the focus at International AIDS Conference
The 30th Medical 10 run
To the Editor: The Medical 10 was first staged in 1978 as a 
result of a letter to the South African Medical Journal by Hendrik 
Muller, a senior physician in Cape Town.1 He pointed out that 
a group of doctors in Finland had organised a 10 km race for 
medical practitioners who felt that it would add credibility 
to recommending a healthy lifestyle to their patients if it 
were shown that they practised what they preached. The 
Metropolitan Life Insurance Company sponsored the event, 
which was run on 9 December at the University of Cape Town. 
Bob Jamieson won on handicap, and the fastest scratch runner 
was Lood Rabie. The results list Clare Stannard as the fastest 
female runner, but she thinks she was beaten by runner No. 88 
(see photo); can anyone identify her?
In 1982, the venue was moved to the University Sports 
Complex in Pinelands, and in 1989 to the Warner Lambert 
facility in Main Road, Retreat. By then it had become an 
established part of the calendar of medical events in the 
Western Cape, not least because of the amusing commentary 
provided by ENT surgeon John Steer, and attracted over 
200 runners plus a group of walkers from the Cardiac 
Rehabilitation Unit. In 2005 the venue moved to the Western 
Province Cricket Club sports complex in Newlands, and 
Life Healthcare took on the sponsorship. Victoria Hospital 
continued to receive the proceeds of the event – over  
R19 000 was donated last year, which enabled them to acquire 
a washing machine for their endoscopy unit. At this stage, 
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entry was opened to the nursing staff and 
paramedical disciplines.
The race retains its uniqueness of being 
run on a handicap basis but, to give the 
scratch runners more chance, the handicap 
was cut from 1 minute to half a minute for 
each year of age over 40.
This year’s event begins at 06h30 on 
Sunday 30 November, and will mark the 
30th staging. We hope that as many as 
possible of those who ran the first race in 
1978 will be able to be present – at least for 
the breakfast, if they are not able to run or 
walk the route.
Entry forms for the 2008 event can be 
obtained from any Life Healthcare hospital 
in the Western Cape or by email from 
Mathilda.mallinson@lifehealthcare.co.za or 
the website www.lifehealthcare.co.za.
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